Secondary analysis of two phase 3 trials in first-line metastatic castration-resistant prostate cancer: adding automated bone and CT imaging to clinical and serum biomarkers improved risk stratification for overall survival but not individual survival predictions.
Secondary analysis
Morris et al. Automated Imaging as an Adjunct to Serum and Clinical Biomarkers: A New Validated Prediction Tool for Metastatic Castration-Resistant Prostate Cancer